Menu
en
de
fr
en
de
fr
Contact
About us
Team
Expertise
Blockchain & Crypto Assets
Capital Markets
Competition & Trade
Compliance
Corporate / M&A
Employment & Pensions
Energy
Environment, Social, Governance (ESG)
Financial Services
Insurance
IP & TMT
Life Sciences
Litigation & Arbitration
Private Clients
Private Equity & Venture Capital
Real Estate & Environment
Restructuring & Insolvency
Tax
White Collar Crime
Insights
Deals & Cases
News
Legal Updates
Publications
Events
Sanctions Resource Center
Corporate Law Reform 2020
Swiss Financial Market Regulation
Careers
Contact
Publication
Loading
COVID-19: Parliamentary discussions on Swiss federal act to legitimise emergency decrees – what is in it for Life Sciences companies?
By
Sarah Drukarch
,
Franz Schubiger
: Legal Update, Zurich 2020
Download PDF
Website
Share
Life Sciences
To the top
